News
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Neurizon Therapeutics.
RELATED STOCKHEAD STORIES
News
10 at 10: These ASX stocks are looking colourful this morning
News
Rise and Shine: What you need to know before the ASX opens
Health & Biotech
Selvax cures cancer in dogs, says it’s eyeing an IPO
News
ASX Small Cap Lunch Wrap: Who scored a lucky number zero today?
Health & Biotech
Health: PharmAust proves its doggie cancer drug works; shares up 40pc
News
10 at 10: These ASX stocks are brewing a storm this morning
News
Rise and Shine: What you need to know before the ASX opens
Health & Biotech
Going viral: All the biggest COVID-19 news from the last week
Health & Biotech
Another day, another handful of companies entering the COVID-19 battle; and they’re all surging
News
10 at 10: These ASX stocks are stirring up a frenzy this morning
Health & Biotech
Dr Boreham’s Crucible: Zelira’s share price could wake up once sales of its pot-based insomnia drug start
Health & Biotech
Health: Alterity gets orphan status for its MSA drug
Health & Biotech
Health: Genetic Tech shares soar on confirmation sales of new breast cancer test are set for Q1
Health & Biotech
Health: GTG back in with breast cancer, hopes to start sales next year
Health & Biotech
Our pets are living longer, happier lives and it’s a $US125bn market; here are the small cap contenders
Health & Biotech
Biotech exec pay — are they delivering returns that equal their pay packets?
Health & Biotech
